MedPath

Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia

Phase 4
Completed
Conditions
Schizophrenia
Psychoses
Interventions
Other: maintained antipsychotic treatment vs. stepwise drug discontinuation
Registration Number
NCT00159120
Lead Sponsor
Heinrich-Heine University, Duesseldorf
Brief Summary

After one year neuroleptic maintenance treatment in patients with first episode schizophrenia, neuroleptic treatment will be continued vs. stepwise discontinued (randomized design) over a period of 1 year. Under both conditions prodrome based early intervention take place.

Detailed Description

After one year neuroleptic maintenance treatment in patients with first episode schizophrenia, neuroleptic treatment will be continued vs. stepwise discontinued (randomized design) over a period of 1 year. Under both conditions pharmacologic early intervention strategies in case of early sign of relapse will be applied.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
71
Inclusion Criteria
  • Patients after 1 year of maintenance treatment after their first-episode in schizophrenia (according ICD-10 F20)
  • Age between 18 and 55
  • Informed consent
  • One year neuroleptic maintenance treatment
  • Reaching stable course
Exclusion Criteria
  • Residence outside of the catchment area
  • Legal reasons
  • Insufficient knowledge of the german language
  • Substance abuse or addiction
  • Pregnancy
  • Serious physical illness
  • Organic brain disease
  • Contraindication to neuroleptic treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1maintained antipsychotic treatment vs. stepwise drug discontinuationfurther maintenance antipsychotic treatment and prodrome-based early intervention
2maintained antipsychotic treatment vs. stepwise drug discontinuationstepwise drug discontinuation (after 1 year maintenance antipsychotic treatment) and prodrome-based early intervention
Primary Outcome Measures
NameTimeMethod
relapse rate1 year
Secondary Outcome Measures
NameTimeMethod
psychopathology1 year
social and cognitive functioning1 year
side-effects1 year
drop-out1 year
quality of life1 year

Trial Locations

Locations (1)

German Research Network on Schizophrenia, Department of Psychiatry and Psychotherapy at the Heinrich-Heine-University Düsseldorf

🇩🇪

Düsseldorf, North Rhine-Westphalia, Germany

© Copyright 2025. All Rights Reserved by MedPath